🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Maria M. Rubinstein

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-7943-8245

Also affiliated with Cornell University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses”.

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses

Nature Medicine(2024)10.1038/s41591-024-02942-7
N/A
0.790DataRank · unranked
26 citations

Beryl Manning‐Geist, Qin Zhou, Tara E. Soumerai, Aliya Holland, Arnaud Da Cruz Paula +23 more

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Gynecologic Oncology(2024)10.1016/j.ygyno.2023.12.028
N/A
0.583DataRank · unranked
12 citations

M. Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth M. Cohen +9 more

Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100873
N/A
0DataRank · unranked
12 citations

Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal +4 more

Microsatellite Instability–High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0713
N/A
0DataRank · unranked
67 citations

Ying L. Liu, Kelly A. Devereaux, Arnaud Da Cruz Paula, Qin Zhou, Weining Ma +18 more

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.028
N/A
0DataRank · unranked
23 citations

Eric Rios Doria, Jason Konner, Stuart M. Lichtman, Qin Zhou, Alexia Iasonos +18 more

Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.012
N/A
0DataRank · unranked
22 citations

Sherry Shen, Bradley J. Monk, David S.P. Tan, Angélica Nogueira‐Rodrigues, Daisuke Aoki +3 more

Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation

International Journal of Gynecological Cancer(2022)10.1136/ijgc-2022-003935
N/A
0DataRank · unranked
10 citations

Sushmita Gordhandas, Anjelica Hodgson, Qin Zhou, Alexia Iasonos, S. Dennis +12 more

Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.09.010
N/A
0DataRank · unranked
19 citations

Weining Ma, Kevin Espino, Sushmita Gordhandas, Effi Yeoshoua, Sarah Ehmann +8 more

Comprehensive analysis of germline drivers in endometrial cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad016
N/A
0DataRank · unranked
21 citations

Eric Rios‐Doria, Karen A. Cadoo, Amanda Catchings, Anna Maio, Yelena Kemel +37 more

Germline drivers of gynecologic carcinosarcomas

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.04.024
N/A
0DataRank · unranked
8 citations

Sushmita Gordhandas, Ozge Ceyhan‐Birsoy, Yelena Kemel, Anna Maio, Erin Salo‐Mullen +22 more

Data from Microsatellite Instability–High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles

(2023)10.1158/1078-0432.c.6532995.v1
N/A
0DataRank · unranked
0 citations

Ying L. Liu, Kelly A. Devereaux, Arnaud Da Cruz Paula, Qin Zhou, Weining Ma +18 more

A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or Recurrent Endometrial Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1999
N/A
0DataRank · unranked
16 citations

Qin Zhou, Alexia Iasonos, William A. Zammarrelli, Britta Weigelt, Lora H. Ellenson +17 more

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.10.019
N/A
0DataRank · unranked
16 citations

Rachel N. Grisham, Karen A. Cadoo, Chrisann Kyi, William P. Tew, Claire F. Friedman +14 more

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.023
N/A
0DataRank · unranked
2 citations

Matthew Flint, M. Herman Chui, Jason Konner, Claire F. Friedman, Angela K. Green +14 more

Targeting obesity-related dysfunction in hormonally driven cancers

British Journal of Cancer(2021)10.1038/s41416-021-01393-y
N/A
0DataRank · unranked
56 citations

Kristy A. Brown, Neil M. Iyengar, Maria M. Rubinstein